At a glance
- Originator Daiichi Pharmaceutical
- Class Hepatoprotectants; Small molecules; Thiazoles
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver disorders
Most Recent Events
- 30 May 2000 Discontinued-Preclinical for Liver disorders prevention in Japan (Unknown route)